Abstract

ROBAYO, Adriana et al. Primeras recomendaciones de consenso SLANH - COLABIOCLI. Acta bioquím. clín. latinoam. [online]. 2023, vol.57, n.1, pp.126-130. ISSN 0325-2957.

Chronic kidney disease (CKD) has a high prevalence worldwide and in Latin America (10 to 20% of the adult population) and is increasing. CKD progresses silently. Opportune diagnosis and treatment are effective in most cases to improve outcomes. Serum creatinine was the main test to assess kidney function, but its reliability is limited. Through the KDOQI Guidelines 2002, the estimated glomerular filtration rate (eGFR) obtained from equations was established as one of the main tools for the early detection of kidney disease in clinical practice. The detection of a decreased eGFR (less than 60 mL/min/1.73 m2) is clinically relevant. This cut-off level establishes the diagnosis of kidney disease in adults. In 2022 SLANH and COLABIOCLI conducted a survey among the clinical laboratories from Latin America. The survey included 237 laboratories, 49% of which did not routinely report the eGFR. Based on this situation, SLANH and COLABIOCLI have elaborated the following consensus recommendations regarding the use of eGFR.

Keywords : Chronic kidney disease; Serum creatinine; Estimated glomerular filtration rate; Consensus.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )